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Abstract 
Objectives: In this study, we quantify the growth variability of tumour cell clones from 
a human leukemia cell line. Materials and methods: We have used microplate 
spectrophotometry to measure the growth kinetics of hundreds of individual cell clones 
from the Molt3 cell line. The growth rate of each clonal population has been estimated 
by fitting experimental data with the logistic equation. Results: The growth rates were 
observed to vary among different clones. Up to six clones with a growth rate above or 
below the mean growth rate of the parent population were further cloned and the growth 
rates of their offsprings were measured. The distribution of the growth rates of the 
subclones did not significantly differ from that of the parent population thus suggesting 
that growth variability has an epigenetic origin. To explain the observed distributions of 
clonal growth rates we have developed a probabilistic model assuming that the 
fluctuations in the number of mitochondria through successive cell cycles are the 
leading cause of growth variability. For fitting purposes, we have estimated 
experimentally by flow cytometry the maximum average number of mitochondria in 
Molt3 cells. The model fits nicely the observed distributions of growth rates, however, 
cells in which the mitochondria were rendered non functional (ρ0 cells) showed only a 
30% reduction in the clonal growth variability with respect to normal cells. 
Conclusions: A tumor cell population is a dynamic ensemble of clones with highly 
variable growth rate. At least part of this variability is due to fluctuations in the number 
of mitochondria. 
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INTRODUCTION 
 
The last decades have been characterised by intense research on the molecular genetics 
of cancer cells. A huge amount of knowledge has been massed on various molecular 
details of tumour initiation, promotion and progression, starting from the central 
discovery of oncogenes and multistep carcinogenesis (Weinberg 1989). More recently, 
some researchers have also endeavoured to understand the interplay among tumour cells 
and the surrounding microenvironment, the latter including normal cells and a plethora 
of extrinsic signals that both tumour and non-tumour cells exchange (Hanahan & 
Weinberg 2000; Fidler 2002). These signals can modify the individual tumour cells' 
behaviour acting, for example, on the expression of genes, and there is also growing 
evidence that normal cells exert epigenetic control on neoplastic behaviour (Barcellos-
Hoff 2001). It is now clear that tumour initiation, promotion and progression is a rather 
complex mixture of events taking place at both the individual cell and at the cell 
population levels (Hanahan & Weinberg 2000; Barcellos-Hoff 2001; Fidler 2002), 
whereby normal cells, tumour cells and their microenvironments represent a non 
reducible ecosystem (see e.g. Chignola et al. 2006, and references cited therein).  
The heterogeneity of the growth kinetics of individual tumours is a known biological 
fact observed both in vitro and in vivo (Laird 1969; Norton 1985; Chignola et al. 1995; 
Wilson 2001). Furthermore, studies on the individual growth of three-dimensional 
tumour cell cultures (spheroids) under controlled conditions have revealed that tumour 
cells are per se an adaptive, self-organising complex biosystem (Deisboeck et al. 2001) 
and show unexpected emerging growth behaviours such as oscillations of the spheroid 
volume (Chignola et al. 1999). These observations have important implications if one 
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takes into account the well known relationships existing between kinetic heterogeneity 
of tumour growth and the outcome of antineoplastic treatments (Laird 1969; Norton 
1985; Chignola et al. 1995; Wilson 2001). There is however a scarcity of studies on the 
quantitative aspects of tumour growth variability (with some notable exceptions, see 
e.g. Fidler 2002; Rubin 2005; and references cited therein) and on explanations of its 
origin at the cellular or subcellular level. 
Recently, the speed of convergence towards the asynchronous state of two human 
leukemia cell populations has been measured by means of an elegant flow cytometry 
method (Chiorino et al. 2001). The results imply that the duration of the cell cycle 
varies through generations in these tumour cell populations and indeed the observed 
variance around the mean cell cycle length was rather high (coefficient of variation 
CV≈18% and 25% for Molt4 and Igrov cells, respectively). We reasoned that if the 
variability of cell cycle duration were a "sufficiently" stable trait - i.e. if the duration 
does not change too much at each cell division - then the variability should propagate to 
daughter cells from individual clones. Thus, cell populations from individual clones (to 
which we refer as clonal populations) should show different growth rates. However, 
measuring these growth rates would require an experimental method that fulfils the 
following conditions: 
1. it should allow to measure the growth of small cell populations; 
2. it should only minimally perturb cell growth; 
3. for statistical purposes, it should be applied to measure the growth of a high number 
of clonal populations. 
Conventional methods for the determination of cell population size, such as direct cell 
counting, ATP quantification or radioactive labelling, cannot therefore be used. 
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Starting from these considerations we set out to develop a spectrophotometric approach 
to measure the growth of cell populations deriving from individual clones of the Molt3 
human leukemia cell lines. The growth rates of hundreds of clonal populations were 
measured and analysed within the framework of a probabilistic model. The results show 
that populations from individual tumour cell clones have different growth rates and that 
this variability is likely to have epigenetic origin. Attempts towards the identification of 
the epigenetic factor(s) involved are also described. 
Cell variants for growth rate are continuously generated in a tumour population, and this 
endogenous variability might confer a greater fitness to the whole population under the 
pressure of selective environments. 
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MATERIALS AND METHODS 
 
Cell culture and cloning conditions 
Cells from the human T lymphoblastoid line Molt3 (ATCC number CRL-1552) were 
cultured in RPMI 1640 medium (Biochrom AG) supplemented with 2 mM glutamine 
(Sigma), 20 mg/l gentamycin (Biochrom AG), and 10% heat-inactivated foetal bovine 
serum (FBS, Biochrom AG).  Cells were grown at 37° C in a humidified 5% CO2 
atmosphere in T75 culture flasks (Greiner Bio-One) and periodically diluted into fresh 
medium to avoid starvation. 
For cloning purposes, cells from exponentially growing cultures were seeded into the 
wells of round-bottomed 96-well culture plates at the concentration of 0.3 cells/well into 
100 µl complete medium. For each cloning experiments cells were dispensed in 5-10 
plates (480-960 wells). It is well known that at these limiting dilutions, the distribution 
of cells into the wells of culture plates follows the Poisson statistics (Lefkovits & 
Waldmann 1979) and hence it is expected that 74% of the wells will contain no cells, 
22% exactly one cell, and the remaining 4% two cells or more. Limiting dilution assays 
showed that, for Molt3 cells, the plating efficiency, i.e. the ratio between the number of 
wells scored as positive for cell growth and the number of expected wells, ranges 
between 0.5 and 0.7 (not shown). Thus, the choice of  seeding the cells at the 
concentration of 0.3 cells/well was dictated by the conflicting needs of obtaining a high 
number of clonal populations from a reasonable number of culture plates. 
 
Growth assays  
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The culture plates used in cloning assays were periodically monitored for cell growth 
using a microplate spectrophotometer  (Powerwave, Bio-Tek Instruments) and raw data 
analysed with the dedicated KC4TM software. For each well, the absorption spectra in 
the wavelength range between 380 and 750 nm were collected and compared to those 
measured for culture wells containing the medium only. The method will be fully 
described in the following section. The method was validated in parallel assays where 
cell growth was also measured by direct cell counting and ATP determination. For both 
assays, cells were initially seeded in 96-wells culture plates at a concentration of 10.000 
cells/ml in 100 µl complete medium. Cells were counted using a Burker chamber under 
a light phase-contrast microscope (Olympus IX51) upon dilution 1:2 with the vital dye 
trypan-blue to exclude death cells. ATP was determined by the luciferine/luciferase 
method using the CellTiter-Glo Luminescent Cell Viability Assay kit (Promega) by 
following the manufacturer's procedures. The emitted light was measured using a 
microplate luminometer (FLX 800, Bio-Tek Instruments) and the data expressed in 
luminescence arbitrary units. For both assays, at each time-point the growth of 6 
independent cultures was measured and averaged data compared to those evaluated by 
spectrophotometry for the same number of cultures grown under identical experimental 
conditions. 
 
Mathematical analysis of growth curves 
The growth data measured for each clonal population were fitted with the logistic 
equation: 
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where y(t) is the population size measured at time t and y0, a, b and t0 are parameters 
that assume positive values. It should be noted that equation (1) describes a growth 
process characterised by an initial exponential phase with growth rate r given by: 
! 
r =
1
b
           (2) 
with a saturation level ym given by: 
! 
ym = lim
t"#
y(t) = y0 + a          (3) 
Equation (1) was automatically fitted to growth data from different clonal populations 
by means of a χ-squared minimisation algorithm written ad hoc in the Mathematica 
v.5.0 environment (Wolfram Research). We used standard statistical quantities, such as 
the standard deviation of estimated parameter values, to accept or reject the results. 
 
Isolation of mitochondria 
Mitochondria were isolated from 107 cells samples. Cells collected by centrifugation 
were washed several times firstly with PBS and then with NKM buffer (0.13 M NaCl, 5 
mM KCl, 7.5 mM MgCl2, 1 mM Tris-HCl pH 7.4) at 4° C. Cell pellets were finally 
resuspended in 700 µl lysis buffer (10 mM KCl, 1.5 mM MgCl2, 1 mM PMSF, 1 mM 
DTT, 10 mM Tris-HCl pH 7.4) and kept on ice for 3 min. Samples were carefully 
homogenised using a glass Potter and 50 µl of a 2 M saccarose solution were added. 
Homogenates were centrifuged at 1200 g for 5 min and the pellets containing intact 
cells and nuclei were discarded. This procedure was repeated for three times. The 
supernatants were then centrifuged at 7000 g for 10 min to separate the protein and the 
microsomal fractions from that of mitochondria. The pellets formed by purified 
mitochondria were finally resuspended in CAB buffer (20 mM Na-HEPES, 0.12 
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mannitol, 80 mM KCl, 1 mM EDTA, pH 7.4) containing a mixture of protases 
inhibitors (Complete tablets, Roche) and stored on ice. 
 
Flow cytometry assays 
Cells and purified mitochondria were stained with 200 nM MitoFluor Red 589 
fluorescent dye (Invitrogen) which is a specific cell membrane-permeable marker for 
mitochondria, and commonly used to measure the mitochondrial mass in intact cells. 
Both cells and mitochondria were incubated with the dye for 30 min at 37° C. Cells 
were then washed with PBS, whereas mitochondria with CAB. 
Cells were also stained for 30 min at 37° C with 5 µM Vybrant DyeCycleTM Green 
Stain (Invitrogen), a fluorescent dye developed to label the cell DNA in intact living 
cells. 
Fluorescence was measured with a FACScalibur flow cytometer (Becton-Dickinson) 
equipped with both Ar and red diode lasers, and data were analysed using the CellQuest 
(Becton-Dickinson) software. 
 
Quantification of mitochondria 
The average number of mitochondria per cell <M> was estimated by flow cytometry. 
Cell populations and isolated mitochondria were labelled with the mitochondria-specific 
fluorescent probe (see above), and the mean fluorescence intensities of labelled and 
unlabelled samples - measured at the same sensitivity of the photomultiplier - were used 
to calculate <M> as follows: 
! 
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where MFI is the measured mean fluorescence intensity of the samples and the 
subscripts C, UC, M and UM refer to intact cells, unlabelled cells, isolated mitochondria 
and unlabelled isolated mitochondria samples, respectively.  
The standard deviation of the average <M> was calculated from the coefficient of 
variation (CV) of measured fluorescence intensity distributions: 
! 
"
C ,UC ,M ,UM
=
MFI
C ,UC ,M ,UM
#CV
100 # n
       (5) 
where n is the number of measured events. The standard deviation of <M> was then 
calculated by applying the usual equations from error propagation theory, which, in this 
case, reduce to the following equation: 
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Preparing ρ0 cells from Molt3 cultures 
ρ0 cells were obtained by culturing Molt3 cells in the presence of 50 ng/ml ethidium 
bromide (Armand et al. 2004). Since the treatment with ethidium bromide inhibits the 
replication of mitochondrial DNA, the mitochondrial DNA is progressively depleted 
and ATP production through oxydative phosphorylation blocked (Armand et al. 2004). 
Cells with non-functional mitochondria cannot survive in standard complete RPMI-
medium, and culture media were therefore supplemented with 100 µg/ml pyruvate and 
50 µg/ml uridine as described in (Armand et al. 2004). Culture media were refreshed at 
3 days intervals. After 24 days, the cells were cloned as described above in the absence 
of ethidium bromide, and clonal populations expanded for further 18 days. The cells 
from each clone were then split in two populations and grown in parallel for 11 days in 
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RPMI medium and medium containing pyruvate and uridine. Cells growing in pyruvate 
and uridine containing medium only were scored as true ρ0.  
ρ0 cells were also subjected to PCR analysis throughout the culture procedure and the 
results were compared to those obtained with normal Molt3 cells. To this purpose the 
DNA was extracted using the Wizard Genomic DNA purification kit (Promega) and 50 
ng of total DNA were subjected to PCR using mitochondrial specific primers 
(Holmuhamedov et al. 2002) and primers for a fragment of the nuclear β-actin gene as 
the control. The primers were as follows: 
1. mitochondrial DNA specific primers (giving an amplicon of 312 bp, Holmuhamedov 
et al. 2002):  
forward: 5'-ACAATAGCTAAGACCCAAACTGGG-3'; 
reverse1: 5'-CCATTTCTTGCCACCTCATGGGC-3'. 
2. nuclear DNA specific primers (giving an amplicon of 311 bp within the β-actin 
gene): 
forward: 5'-CATTGCTCCTCCTGAGCGCAAG-3'; 
reverse: 5'-GCTGTCACCTTCACCGTTCCAG-3'. 
The amplification products obtained after 30 PCR cycles were analysed by 
electrophoresis onto 1% agarose gels. 
 
Descriptive statistics 
                                                
1 The primers were designed based on the data published  in (Holmuhamedov et al. 
2002). The sequence of our reverse primer, however, corresponds to the complementary 
sequence given in (Holmuhamedov et al. 2002) and indeed sequence alignment analysis 
showed that the two primers described by those Authors incorrectly bind the same DNA 
strand. In addition, our sequence was reduced by 1 base to limit the difference in the 
melting temperatures between the forward and the reverse mitochondrial DNA specific 
primers. 
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Where indicated in the next section, we compared experimental data with the two-tailed 
Student t test. Probability threshold values P<0.05 or P<0.01 were considered to reject 
the null-hypothesis and hence to define the differences between the data as statistically 
significant or highly significant, respectively. 
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RESULTS 
 
Measuring cell growth by microplate spectrophotometry 
Fig.1A shows the mean spectra measured for 60 wells of a microplate containing an 
initial cell number of 1.000 cells/well in 100 µl of complete growth medium and, for 
comparison, the mean spectra measured for 60 wells containing medium only. Two 
peaks at 410 nm and 560 nm are visible and these correspond to the absorbance 
properties of the pH-sensitive dye phenol-red used in RPMI growth medium. The 
absorbance intensities of the two peaks varied in time as a consequence of cell growth 
and hence of the acidification of the medium due to lactic acid secretion by cells. Only a 
slight variation in the absorption spectra was measured for the wells containing growth 
medium only. At the 730 nm wavelength, the spectra were not influenced by the 
absorption of phenol-red. At 730 nm the optical density of the cell samples increased 
with time, and the measures were not dependent upon temperature at least within the 
range 25-40 °C (not shown).  
To test whether this increase correlated with cell growth the average optical density at 
730 nm measured for 6 cell populations was compared to two independent measures of 
cell growth, namely direct cell counting (Fig.1B) and ATP determination (Fig.1C). 
These were obtained in parallel experiments carried out under identical growth 
conditions.  
The major difference between the three methods is that microplate spectrophotometry is 
not sensitive to cell death due to starvation taking place at the end of the growth assay. 
Dead cells are not immediately removed from cell cultures and hence they interfere with 
the optical measurements. However, as far as the growth rate is concerned, microplate 
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spectrophotometry is well suited to carry out measurements  (see Fig.1B), and indeed it 
has the following great advantages over the other methods: 
1. since cell sampling is not necessary to carry out measurements, the growth of 
individual cell populations can be measured in time;  
2. as a consequence of the above point, one can avoid to make replicates of the same 
cell culture; 
3. measurements only minimally perturb cell cultures; 
4. it takes just a few minutes to measure the growth occurring in 96 wells.  
Thus the growth of individual populations from cell clones can be measured (Fig.1D) 
and data fitted with growth equation (1).  
 
Growth rate variability of individual cell clones 
Molt3 cells were cloned, and the growth of 201 clonal populations - from three 
independent experiments  - was measured by microplate spectrophotometry. The growth 
rate of each clonal population was estimated by fitting data with equation (1). The 
growth rates of  Molt3 clones distributed as shown in Fig.2 and the mean value was  
found to be 1.128 ± 0.036 days-1.  
The variability of growth rates among different clonal populations can have either a 
genetic or an epigenetic origin or both. We reasoned that if the origin were genetic then 
the trait should have been conserved in the offsprings of a given clone. Six clones from 
the cloning experiments of Molt3 cells were therefore selected at random and their 
individual growth rate is reported in Fig.2. Two of the six selected clones (named as 
follows: number of microplate followed by the well coordinate) had a growth rate below 
the mean value of the Molt3 population whereas the other 4 had a value above that. The 
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six clones were expanded up to populations sizes of  ≈106 cells and further cloned. The 
growth rates of the offsprings of the two clones with an initial growth rate below the 
mean value measured for Molt3 cells and those from the 4 clones with a growth rate 
value above were grouped and their distributions analysed. Grouping was considered to 
minimize the source of errors given by the small number of isolated and measured 
subclones. As it can be appreciated in Fig.2, these distributions were qualitatively 
similar to that shown by the parent population. Indeed, the mean growth rate calculated 
for 82 clonal populations from the clones with initial growth rate below the mean value 
of Molt3 cells, and that calculated for 161 clonal populations from the clones with 
initial growth rate above the mean value of Molt3 cells were not significantly different 
to that of the parent Molt3 population (P>>0.05 in both cases, Student's t test).  
Thus, growth variability of individual tumour cell clones is not a genetically inherited 
trait; rather, it is likely to have an epigenetic origin. 
 
A theoretical hypothesis for the observed growth variability of clonal populations: 
mitochondria as the possible epigenetic cause 
We attempted to explain the observed distributions of growth rates (see e.g. Fig.2) from 
a probabilistic perspective. To do this, we supposed that some epigenetic factor (Ef) 
existed in the cells and  had the following properties: 
1. the growth rate of a clonal population is proportional to the average amount of the Ef; 
2. the Ef is randomly distributed at mitosis to newborn cells; 
3. the Ef must increase its size during the cells cycle up to a maximum value that 
approximately doubles its initial size at mitosis. 
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Condition 2. is required to allow the offsprings of a cell clone to randomly change their 
growth rates. The last condition has instead a mechanistic justification: if the Ef did not 
grow during the cell cycle, or conversely if it did grow too much, then the daughter cells 
would receive a progressively lower or higher amount of the Ef, respectively.  
Mitochondria are known to provide the vast majority of energy to tumour cells grown in 
vitro under the form of ATP, and this energy is used by cells to accomplish the various 
tasks of molecular synthesis required to progress along the cell cycle. In addition, 
mitochondria - as well as other cell organelles - are known to be randomly partitioned to 
the two daughter cells at mitosis (Birky 1983) and are known to double their number 
during the cell cycle (Posakony et al. 1977; James & Bohman 1981). The latter 
biological property was further assayed experimentally here by flow cytometry 
(Fig.3A). 
Thus mitochondria are good candidates as the Ef causing the growth variability of 
tumour cell clones, and the probabilistic model that we have developed on the basis of 
the above considerations writes as follows (see the Appendix for details): 
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where 
! 
P
r(M )
(r) is the probability density of growth rates r distributions, k is the (linear, 
see the Appendix) growth rate of mitochondria, M0 is the maximum average number of 
mitochondria in the cells (i.e. the maximum average number of mitochondria before 
mitosis and ranging, among different cells, between Mmin and Mmax) and 
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standard deviation that parametrize the fluctuations of M around M0. It should be noted 
that three parameters are considered in equation (7), namely k, M0 and 
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, two of 
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which are correlated (M0 and 
! 
"
M
). To estimate the values of these parameters by fitting, 
an independent measure of M0 or of 
! 
"
M
 is therefore required. 
For this reason, we estimated M0 experimentally by flow cytometry (Fig.3B). It should 
be noted that for fitting purposes the knowledge of the exact maximum number of 
mitochondria in the cells is not required and that a rough estimate is sufficient.  Cells 
and isolated mitochondria were labelled with a mitochondria-specific fluorescent probe 
and measurements were processed as described in the Material and Methods section 
(Fig.3B). These calculations allowed us to estimate the mean number of mitochondria in 
the Molt3 cell population that turned out to be <M> = 225.7 ± 3.9, a number in 
agreement with values reported also by others (Robin & Wong 1988). This estimate, 
however, corresponds to the average number of mitochondria in the desynchronized cell 
population. M0 was therefore computed by assuming that the growth of mitochondria is 
linear in time (see also Posakony et al. 1977; James & Bohman 1981), that cells are 
evenly distributed in their cycles and that, as confirmed experimentally (Fig.3A), 
mitochondria double their initial number before mitosis. Thus: 
! 
M
0
"
4
3
< M >= 300.9         (8) 
The above value was substituted in equation (7) and this equation, now with only two 
free and independent parameters, was numerically solved and fitted to growth rate 
distributions from independent experiments with Molt3 cells (Fig.4). The fits showed 
good agreement between theory and experiments. 
 
Growth rate variability of ρ0 cells 
The results shown in Fig.4 suggest that the observed growth variability of Molt3 clones 
is correlated to the variability in the number of mitochondria they possess and transmit 
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to their offsprings.  If this were the biological basis of the growth variability of 
individual clones, then Molt3 cells in which mitochondria are rendered non functional - 
the so-called  ρ0 cells - should grow with less variable kinetics with respect to normal 
Molt3 cells.  
We obtained ρ0 cells by culturing Molt3 cells in the presence of ethidium bromide as 
described in the Materials and Methods section and they were identified and selected on 
the basis of: 
1. loss of mitochondrial DNA (Fig.5A); 
2. dependence on uridine and pyruvate for survival (see Materials and Methods). 
Molt3 ρ0 cells were then expanded and cloned, and the growth kinetics of individual 
clonal populations were analysed as described for normal Molt3 cells. The distribution 
of growth rates measured for 41 clonal populations is shown in Fig.5B. With respect to 
that of normal Molt3 cells (see e.g. Fig.2), this distribution appears shifted to the left 
and this is due to the growth kinetics of ρ0 cells which resulted approximately 2.1 times 
slower than that of normal Molt3 cells (mean ± SE growth rate of 1.13 ± 0.036 and of 
0.53 ± 0.026 days-1 for normal and  ρ0 cells, respectively). The relative variability of 
growth rates was approximately 30% lower for ρ0 cells with respect to normal cells (CV 
45.1 % and 31.5 % for normal and ρ0 cells, respectively). Thus, we conclude that the 
fluctuations in the number of mitochondria: 
1. in general, are correlated to the growth variability of individual clones; 
2. in particular, determine approximately 30% of the growth variability. 
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DISCUSSION 
 
The fact that a tumour population is a heterogeneous ensemble of cell variants for a 
given trait has long been recognised, starting from the pioneering works on the 
spontaneous transformation of embryo fibroblasts in vitro and on the individual 
metastatic potential shown by tumour cell clones in vivo (see e.g. Fidler 2002; Rubin 
2005; and references cited therein). These traits have been observed to vary among 
successive cell generations, and the pressure of environmental selection on genetically-
determined cell variants has been shown to play a pivotal role in allowing the onset of 
dominant - often more aggressive - variants (Fidler 2002; Rubin 2005). Thus, the 
growth of a tumour can be viewed as an evolutionary process whereby tumour cells, 
normal cells and environmental niches constitute a dynamical ecosystem (Hanahan & 
Weinberg 2000; Barcellos-Hoff 2001; Vineis 2003; Fidler 2002; Rubin 2005). As 
expected, both genetic and epigenetic forces act to sustain competition between tumour 
and normal cells (Hanahan & Weinberg 2000; Barcellos-Hoff 2001; Vineis 2003; Fidler 
2002; Rubin 2005). 
The duration of the cell cycle is recognised among the phenotypic traits that can vary in 
a tumour cell population (see e.g. Chiorino et al. 2001 and references cited therein), and 
indeed the heterogeneity of tumour growth kinetics is known to have serious 
implications for tumour treatment (Laird 1969; Norton 1985; Chignola et al. 1995; 
Wilson 2001). For this reason, the variability in cell cycle duration has been extensively 
investigated for tumour cells both experimentally and theoretically (see e.g. Chiorino et 
al. 2001 and references cited therein). In particular, statistical approaches have been 
used to model experimental data taken at the level of whole tumour cell populations, 
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where inter-cell variability was indirectly estimated by the mathematical analysis of 
data obtained in pulse-chase experiments with radioactive-labelled DNA bases (see e.g. 
Wilson 2001) or, more recently, with fluorescent probes (Chiorino et al. 2001). The 
direct measurements of cell cycle duration at single cell level has obvious technical 
limitations. Thus, we attempted to approach the problem from an experimental 
perspective that lies somewhat in between the two extremes represented by whole-
population and single-cell measurements. We have shown that: 
1. the heterogeneity in the growth kinetics of clonal populations, i.e. of small 
populations from a single tumour cell clone, can be measured in vitro; 
2. the growth variability among clonal populations is likely to be determined at the 
epigenetic level. 
Although we could not determine how the stability of this trait through generations, the 
data show that clonal populations after 20 days of culture - i.e. approximately 20 
generations - possess a high degree of variability in their growth kinetics. The 
unexpected result, therefore, is that the variability in cell cycle duration among 
individual clones appears to propagate to their offsprings. This has allowed us to 
measure different growth kinetics for different clonal populations, after all. Propagation 
of the trait, on the other hand, is unlikely to be caused by genetic forces since the 
growth variability of populations generated by subclones have the same variability as 
the parent population and hence the trait is not fixed in the progeny. This means that the 
fluctuations of the "epigenetic factor" must be represented by a stochastic process with 
memory. 
The variability in the cell cycle kinetics has been assumed to stem from unequal cell 
size division or from fluctuations in the concentration of some cellular components (see 
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e.g. Chiorino et al. 2001 and references cited therein), both processes taking place at 
mitosis. These considerations have led us to hypothesise a role for mitochondria, but the 
data obtained with ρ0 cells show that the fluctuations in the number of mitochondria 
take account of 30% only of the growth variability of clonal populations. Thus, the most 
important epigenetic factor(s) behind growth variability of tumour cell clones still 
remains to be identified. 
Our data, however, indicate that a tumour population is a dynamic ensemble of noisy 
cell units. It is worth noting that noise, under the form of fluctuations in the 
concentrations of key molecules, can drive the differential expression of genes in 
otherwise identical cells (McAdams & Arkin 1999). This form of noise might also lead 
to different cycle times for individual clones thus determining the variability of growth 
rates and perhaps of  the growth saturation levels. In fact, an open question that has not 
been addressed here is that clonal populations also reached different saturation levels 
(see e.g. Fig.1D) and we did not observe correlation with the growth rates (not shown). 
A new testable hypothesis to explain the observed variability of both growth rate  and 
saturation level of clonal populations is therefore required. 
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APPENDIX 
 
A probabilistic model of the growth rate variability of tumor cell clones 
Since the variability of growth rates is likely to have an epigenetic origin (see the 
Results section) we assumed that an epigenetic factor (Ef) is randomly distributed at 
mitosis, and that the amount of inherited Ef determines the cell cycle duration in the 
daughter cells. Given their biological significance, we identified mitochondria as a good 
candidate Ef, and hence the model refers to the number of mitochondria as the 
stochastic variable. However, it should be noted that the model might apply to other 
cellular organelles and/or molecular mechanisms provided the following assumptions 
holds: 
1. during the cell cycle the Ef approximately doubles its size and the growth is linear 
with time. This assumption holds for mitochondria (Posakony et al. 1977; James & 
Bohman 1981); 
2. the Ef can be represented by a stochastic variable and daughter cells inherit random 
amounts of the Ef. Mitochondria fulfil this assumption as they have been observed to be 
randomly partitioned at mitosis (Birky 1983); 
3. at mitosis the Ef is partitioned at random between the two daughter cells with equal 
probability. Mitochondria fulfil also this assumption as they are known to be distributed 
to daughter cells with equal probability and their distribution appears to follow a 
binomial distribution;  
4. cells are supposed to divide when Ef reaches a maximum value Ef (max), and for this 
reason the amount of Ef in each generation is independent from that in previous 
generations (and cell division erases all existing memory). 
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From assumption 3, if the mother cell has M mitochondria at division, the probability of 
finding m mitochondria in a given daughter cell is: 
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It is well-known that when M >> 1, the binomial distribuion (A1) is well approximated 
by a Gaussian distribution with mean M and standard deviation 
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From assumption 1, if m is the number of mitochondria at the start of the cell cycle, M 
is the number of mitochondria at division and k is the mitochondrial proliferation rate, 
then: 
! 
M = m + kT           (A3) 
where T=1/r is the cell doubling time and r the corresponding growth rate. Now, using 
the standard formulas for the substitution of random variables in probability densities 
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we find the probability density for the growth rate r:  
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In equations (A1) to (A5) we have implicitly assumed a fixed M, but obviously the 
maximum number of mitochondria is itself subject to fluctuations  about a mean value 
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M0: if we assume that the fluctuations of M are approximately Gaussian with variance 
! 
" 2M , then the probability density (A5) is transformed into a new density  
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which depends on the two random variables r and M. Now, using the terminology of 
Bayesian  statistics, M is a “nuisance variable”, and we eliminate it as usual by 
marginalizing the density (A6), i.e., by integrating out the nuisance variable M:  
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where (Mmin,Mmax) is the range of M, and for all practical purposes we can take  
M
max
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, where n ! 3 . 
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FIGURE CAPTIONS 
 
Fig.1 - Measuring the growth of tumour cells by microplate spectrophotometry. A. 
Mean absorption spectra measured at the indicated times for  60 wells containing an 
initial number of about 1000 cells (solid lines) and for 60 wells containing growth 
medium only (dashed lines). The SD is not shown for the sake of clarity, however the 
observed maximum CV was <2%. B. The growth of 6 cell populations from an initial 
cell density of 10000 cells/ml was measured by microplate spectrophotometry at the 
730 nm wavelength and data averaged (black circles). For comparison, cell growth was 
measured in parallel for 6 independent cell cultures grown under the same experimental 
conditions by counting the cells at the microscope using the trypan-blue dye exclusion 
assay (open squares). C. The same spectrophotometric data shown in B are here 
compared to ATP measurements by the luciferine/luciferase method carried out on 6 
independent cell cultures grown under the same experimental conditions. D. Four Molt3 
cell clones were isolated in different wells of a microplate and their growth monitored 
in situ by spectrophotometry. The lines represent the best fits obtained with equation 
(1). The figure provides an example of the observed growth variability of clonal 
populations. 
 
Fig.2 - Epigenetic basis of the growth variability of tumour cell clones. Molt3 cells were 
cloned and the growth rate of each clonal population was estimated by fitting 
experimental data with equation (1) as shown also in Fig.1D. The distribution of the 
growth rates measured for N=201 clonal populations is shown along with the mean±SD 
growth rate r.  Six clones growing with the indicated rates (rp), where the index p 
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denotes that the rate is the mean rate of the clonal population, were then selected and 
cells expanded in T25 culture flasks for 4 days. Two out of six clones showed a growth 
rate below the mean value observed for cloned Molt3 cells and the other 4 a value 
above. Then, cells from these populations were further cloned and the mean ± SD value 
measured for the indicated number of clonal populations obtained is reported. For 
statistical purposes, the growth rates measured for the clonal populations obtained from 
the 6 initially selected clones were grouped as indicated and  the two distributions 
obtained are shown in the figure. These distribution are similar to that of the parent 
Molt3 populations. The mean growth rates do not significantly differ  from that of the 
parent population (Student t test, P>>0.05). Thus, "the growth rate" is not a genetically 
inheritable trait. 
 
Fig.3 - Flow cytometry experiments for the analysis of mitochondria in Molt3 cells. A. 
Bi-parametric analysis carried out with mitochondria and nuclear DNA specific 
fluorescent probes. On average, the number of mitochondria in G2/M phase 
approximately doubles the value observed for cells in G1. B. Mitochondria isolated 
from Molt3 cells (upper panel) and mitochondria in intact cells (bottom panel) were 
loaded with a specific fluorescent probe and analysed. The fluorescence intensity was 
collected for both samples at the same sensitivity of the photomultiplier. The black-
filled distributions of fluorescence intensity values show the data obtained for 
unlabelled mitochondria and cells. 
 
Fig.4 - Distributions of the growth rates of Molt3 clones and fits with model equation 
(7). The distributions of the growth rates measured for Molt3 clones from 3 independent 
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experiments are shown (A, B and C). The values measured in these experiments were 
also grouped and analysed (right panel). In all figures, the line represents the best fit 
obtained with equation (7), the symbol N refers to the number of analysed clones, k is 
the linear growth rate of mitochondria estimated by data fitting and σ is the estimated 
standard deviation of the fluctuations of the maximum number of mitochondria around 
the mean number (see the text for details). 
 
Fig.5 - Distributions of the growth rates of Molt3 ρ0 cell clones. A. PCR analysis of ρ0 
cells. In each lane, 25 µl of the PCR products were loaded. Lanes are as follows: 1. 
nuclear β-actin gene fragment, normal cells; 2. mitochondria DNA-specific fragment, 
normal cells; 3. nuclear β-actin gene fragment, ρ0 cells; 4. mitochondria DNA-specific 
fragment, ρ0 cells. Traces of mitochondrial DNA are commonly visible in ρ0 cells (see 
also Armand et al. 2004). Thus, to demonstrate that these cells are true ρ0 functional 
assays must also be performed and in this paper we have monitored their dependence on 
uridine and pyruvate for survival. B. Distribution of the growth rates of ρ0 cell clones. 
Data are plotted on the same x-axis scale as that used for normal cells for comparison 
(see Fig.2). 
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